Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury

Journal of Neurotrauma

Volumn 31, Issue 16, 2014, Pages 1405-1416

  Arien Zakay, Hadar ^a   Gincberg, Galit ^a   Nagler, Arnon ^b   Cohen, Gadi ^a   Liraz Zaltsman, Sigal ^a   Trembovler, Victoria ^a   Alexandrovich, Alexander G ^a   Matok, Ilan ^a   Galski, Hanan ^b   Elchalal, Uriel ^c   Lelkes, Peter I ^d   Lazarovici, Philip ^a   Shohami, Esther ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d Temple University   (United States)

Author keywords

brain trauma; cell transplantation; cord blood; neurotherapy

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CD11B ANTIGEN; CD45 ANTIGEN; NERVE GROWTH FACTOR; VASCULOTROPIN; PTPRC PROTEIN, HUMAN;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BRAIN DAMAGE; BRAIN HEMATOMA; BRAIN SLICE; BRAIN VENTRICLE; CD 45 HEMATOPOIETIC CELL; CELL DENSITY; CELL POPULATION; COGNITION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC CELL; HEMISPHERE; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; THERAPY EFFECT; THERMOGRAPHY; TRAUMATIC BRAIN INJURY; UMBILICAL CORD BLOOD; ANIMAL; BRAIN INJURIES; CELL SEPARATION; CONVALESCENCE; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; PROCEDURES;

ANIMALS; ANTIGENS, CD45; BRAIN INJURIES; CELL SEPARATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; MALE; MICE; RECOVERY OF FUNCTION;

EID: 84907417598     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.3270     Document Type: Article

References (53)

1. Beauchamp, K., Mutlak, H., Smith, W.R., Shohami, E, and Stahel, P.F. (2008). Pharmacology of traumatic brain injury: where is the ''golden bullet''? Mol. Med. 14, 731-740.
2. Mustafa, A.G. and Alshboul, O.A. (2013). Pathophysiology of traumatic brain injury. Neurosciences (Riyadh) 18, 222-234.
3. Leker, R.R. and Shohami, E. (2002). Cerebral ischemia and traumadifferent etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev. 39, 55-73.
4. Chen, Y., Constantini, S., Trembovler, V.,Weinstock, M., and Shohami, E. (1996). An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J. Neurotrauma 13, 557-568.
5. Yatsiv, I., Grigoriadis, N., Simeonidou, C., Stahel, P.F., Schmidt, O.I., Alexandrovitch, A.G., Tsenter, J., and Shohami, E. (2005). Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 19, 1701-1703.
6. Liraz-Zaltsman, S., Alexandrovich, A.G., Trembovler, V., Fishbein, I., Yaka, R., Shohami, E., and Biegon, A. (2011). Regional sensitivity to neuroinflammation: in vivo and in vitro studies. Synapse 65, 634-642.
7. Shohami, E. and Biegon, A. (2011). Controversial findings on the role of NMDA receptors in traumatic brain injury. In: Traumatic brain and spinal cord injury. Morganti-Kossman, Raghupathi, Maas (eds). Cambridge University Press: UK.
8. Trounson, A., Thakar, R.G., Lomax, G., and Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Med. 9, 52.
9. McGuckin, C.P. and Forraz, N. (2008). Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif. 41 Suppl 1, 31-40.
10. Arien-Zakay, H., Lazarovici, P. and Nagler, A. (2010). Tissue regeneration potential in human umbilical cord blood. Best Pract. Res. Clin. Haematol. 23, 291-303.
11. Harris, D.T. and Rogers, I. (2007). Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr. Stem Cell Res. Ther. 2, 301-309.
12. Nielsen, J.S. and McNagny, K.M. (2008). Novel functions of the CD34 family. J. Cell Sci. 121, 3683-3692.
13. Meregalli, M., Farini, A., Belicchi, M., and Torrente, Y. (2010). CD133( + ) cells isolated from various sources and their role in future clinical perspectives. Expert Opin. Biol. Ther. 10, 1521-1528.
14. Craig, W., Poppema, S., Little, M.T., Dragowska, W., and Lansdorp, P.M. (1994). CD45 isoform expression on human haemopoietic cells at different stages of development. Br. J. Haematol. 88, 24-30.
15. Dahlke, M.H., Larsen, S.R., Rasko, J.E., and Schlitt, H.J. (2004). The biology of CD45 and its use as a therapeutic target. Leuk. Lymphoma 45, 229-236.
16. Huntington, N.D. and Tarlinton, D.M. (2004). CD45: direct and indirect government of immune regulation. Immunol. Lett. 94, 167-174.
17. Shivtiel, S., Kollet, O., Lapid, K., Schajnovitz, A., Goichberg, P., Kalinkovich, A., Shezen, E., Tesio, M., Netzer, N., Petit, I., Sharir, A., and Lapidot, T. (2008). CD45 regulates retention, motility, and numbers of hematopoietic progenitors, and affects osteoclast remodeling of metaphyseal trabecules. J. Exp. Med. 205, 2381-2395.
18. Stanevsky, A., Shimoni, A., Yerushalmi, R., and Nagler, A. (2011). Cord blood stem cells for hematopoietic transplantation. Stem Cell Rev. 7, 425-433.
19. Nan, Z., Grande, A., Sanberg, C.D., Sanberg, P.R., and Low, W.C. (2005). Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann. N. Y. Acad. Sci. 1049, 84-96.
20. Chen, S.H., Chang, F.M., Tsai, Y.C., Huang, K.F., Lin, C.L., and Lin, M.T. (2006). Infusion of human umbilical cord blood cells protect against cerebral ischemia and damage during heatstroke in the rat. Exp. Neurol. 99, 67-76.
21. Chen, J., Sanberg, P.R., Li, Y., Wang, L., Lu, M., Willing, A.E., Sanchez-Ramos, J., and Chopp, M. (2001). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688.
22. Chen, C.T., Foo, N.H., Liu, W.S., and Chen, S.H. (2008). Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatr. Neonatol. 49, 77-83.
23. Lu, D., Sanberg, P.R., Mahmood, A., Li, Y., Wang, L., Sanchez-Ramos, J., and Chopp, M. (2002). Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11, 275-281.
24. Wang, S., Cheng, H., Dai, G., Wang, X., Hua, R., Liu, X., Wang, P., Chen, G., Yue, W., and An, Y. (2013). Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 1532, 76-84.
25. Zanier, E.R., Montinaro, M., Vigano, M., Villa, P., Fumagalli, S., Pischiutta, F., Longhi, L., Leoni, M.L., Rebulla, P., Stocchetti, N., Lazzari, L., and De Simoni, M.G. (2011). Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma. Crit. Care Med. 39, 2501-2510.
26. Wexler, S.A., Donaldson, C., Denning-Kendall, P., Rice, C., Bradley, B. and Hows, J.M. (2003). Adult bone marrow is a rich source of human mesenchymal ?stem' cells but umbilical cord and mobilized adult blood are not. Br. J. Haematol. 121, 368-374.
27. Gorczyca, W., Sun, Z.Y., Cronin, W., Li, X., Mau, S., and Tugulea, S. (2011). Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol. 103, 221-266.
28. Arien-Zakay, H., Nagler, A., Galski, H., and Lazarovici, P. (2007). Neuronal conditioning medium and nerve growth factor induce neuronal differentiation of collagen-adherent progenitors derived from human umbilical cord blood. J. Mol. Neurosci. 32, 179-191.
29. Shivtiel, S., Lapid, K., Kalchenko, V., Avigdor, A., Goichberg, P., Kalinkovich, A., Nagler, A., Kollet, O., and Lapidot, T. (2011). CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice. Exp. Hematol. 39, 1161-1170.
30. Beni-Adani, L., Gozes, I., Cohen, Y., Assaf, Y., Steingart, R.A., Brenneman, D.E., Eizenberg, O., Trembolver, V. and Shohami, E. (2001). A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice. J. Pharmacol. Exp. Ther. 296, 57-63.
31. Tsenter, J., Beni-Adani, L., Assaf, Y., Alexandrovich, A.G., Trembovler, V. and Shohami, E. (2008). Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J. Neurotrauma 25, 324-333.
32. Cohen, G., Lecht, S., Arien-Zakay, H., Ettinger, K., Amsalem, O., Oron-Herman, M., Yavin, E., Prus, D., Benita, S., Nissan, A., and Lazarovici, P. (2012). Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor. PLoS One 7, e48803.
33. Neuhoff, S., Moers, J., Rieks, M., Grunwald, T., Jensen, A., Dermietzel, R., and Meier, C. (2007). Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp. Hematol. 35, 1119-1131.
34. Sanchez-Pernaute, R., Studer, L., Ferrari, D., Perrier, A., Lee, H., Vinuela, A., and Isacson, O. (2005). Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells 23, 914-922.
35. Sugiyama, T., Kuroda, S., Osanai, T., Shichinohe, H., Kuge, Y., Ito, M., Kawabori, M., and Iwasaki, Y. (2011). Near-infrared fluorescence labeling allows noninvasive tracking of bone marrow stromal cells transplanted into rat infarct brain. Neurosurgery 68, 1036-1047.
36. Paxinos, G. and Franklin, K.B.J. (2004). The Mouse Brain in Stereotaxic Coordinates. Elsevier Academic Press: Waltham, Massachusetts.
37. Teicher, B.A. and Fricker, S.P. (2010). CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin. Cancer Res. 16, 2927-2931.
38. Zola, H. (2006). Medical applications of leukocyte surface molecules- the CD molecules. Mol. Med. 12, 312-316.
39. Augello, A., Kurth, T.B. and De Bari, C. (2010). Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur. Cell Mater. 20, 121-133.
40. Davis, S.M. and Donnan, G.A. (2009). 4.5 hours: the new time window for tissue plasminogen activator in stroke. Stroke 40, 2266-2267.
41. Stanevsky, A., Shimoni, A., Yerushalmi, R., and Nagler, A. (2010). Double umbilical cord blood transplant: more than a cell dose? Leuk. Lymphoma 51, 975-982.
42. Arien-Zakay, H., Lecht, S., Bercu, M.M., Tabakman, R., Kohen, R., Galski, H., Nagler, A., and Lazarovici, P. (2009). Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp. Neurol. 216, 83-94.
43. Menon, D.K. (2009). Unique challenges in clinical trials in traumatic brain injury. Crit. Care Med. 37, S129-S135.
44. Kumar, A. and Loane, D.J. (2012). Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav. Immun. 26, 1191-1201.
45. Gincberg, G., Arien-Zakay, H., Lazarovici, P., and Lelkes, P.I. (2012). Neural stem cells: therapeutic potential for neurodegenerative diseases. Br. Med. Bull. 104, 7-19.
46. Maurya, D.K., Doi, C., Pyle, M., Rachakatla, R.S., Davis, D., Tamura, M., and Troyer, D. (2011). Non-random tissue distribution of human naive umbilical cord matrix stem cells. World J. Stem Cells 3, 34-42.
47. Andres, R.H., Choi, R., Pendharkar, A.V., Gaeta, X., Wang, N., Nathan, J.K., Chua, J.Y., Lee, S.W., Palmer, T.D., Steinberg, G.K., and Guzman, R. (2011). The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42, 2923-2931.
48. Deng, J., Zou, Z.M., Zhou, T.L., Su, Y.P., Ai, G.P., Wang, J.P., Xu, H., and Dong, S.W. (2011). Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol. Sci. 32, 641-651.
49. Yoon, J.K., Park, B.N., Shim, W.Y., Shin, J.Y., Lee, G., and Ahn, Y.H. (2010). In vivo tracking of 111In-labeled bone marrow mesenchymal stem cells in acute brain trauma model. Nucl. Med. Biol. 37, 381-388.
50. Zangiacomi, V., Balon, N., Maddens, S., Tiberghien, P., Versaux-Botteri, C., and Deschaseaux, F. (2009). Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA. Stem Cells Dev. 18, 1369-1378.
51. Spiegel, A., Shivtiel, S., Kalinkovich, A., Ludin, A., Netzer, N., Goichberg, P., Azaria, Y., Resnick, I., Hardan, I., Ben-Hur, H., Nagler, A., Rubinstein, M., and Lapidot, T. (2007). Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34 + cells through Wnt signaling. Nat. Immunol. 8, 1123-1131.
52. Longhi, L., Zanier, E.R., Royo, N., Stocchetti, N., and McIntosh, T.K. (2005). Stem cell transplantation as a therapeutic strategy for traumatic brain injury. Transpl. Immunol. 15, 143-148.
53. Mahmood, A., Lu, D., and Chopp, M. (2004). Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 21, 33-39.